Priority 4 from the Cavernoma PSP
| UNCERTAINTY: Could drugs targeted at cavernomas improve outcome for people with brain or spine cavernomas compared to no drug treatment? (JLA PSP Priority 4) | |
|---|---|
| Overall ranking | 4 |
| JLA question ID | 0035/4 |
| Explanatory note | Not available for this PSP |
| Evidence |
No evidence found |
| Health Research Classification System category | Neurological |
| Extra information provided by this PSP | |
|---|---|
| Original uncertainty examples | Not available |
| Comparison | Prognosis |
| Submitted by | 45 patients |
| Outcomes to be measured | Change of symptoms |
| PSP information | |
|---|---|
| PSP unique ID | 0035 |
| PSP name | Cavernoma |
| Total number of uncertainties identified by this PSP. | 54 |
| Date of priority setting workshop | 23 September 2015 |